Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 509

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis

Guillevin, Loïc, Cordier, Jean‐François, Lhote, Franïois, Cohen, Pascal, Jarrousse, Bernard, Royer, Isabelle, Lesavre, Philippe, Jacquot, Christian, Bindi, Pascal, Bielefeld, Philippe, Desson, Jean‐Franïois, Détrée, Frédérick, Dubois, Alain, Hachulla, Eric, Hoen, Bruno, Jacomy, Dominique, Seigneuric, Christian, Lauque, Dominique, Stern, Marc, Longy‐Boursier, Maité·1997·Arthritis & Rheumatism

Abstract

Objective. To investigate the effectiveness and side effects of oral versus pulse cyclophosphamide (CYC) in combination with corticosteroids (CS) in the treatment of systemic Wegener's granulomatosis (WG). Methods. Patients with newly diagnosed systemic WG were enrolled in a prospective, randomized trial. At the time of diagnosis, prior to randomization, every patient received a daily injection of methylprednisolone for 3 days, followed by daily oral prednisone (1 mg/kg/day) and a 0.7‐gm/m 2 pulse of CYC. Patients were then randomly assigned to receive either prednisone plus intravenous pulse CYC (group A) or prednisone plus oral CYC (group B) as first‐line treatment. CYC was given for at least 1 year and was then progressively tapered and discontinued. Results. Fifty patients were included in the study: 27 in group A and 23 in group B. At 6 months, 24 group A patients (88.9%) were in remission, versus 18 group B patients (78.3%). At the end of the trial, 18 group A patients (66.7%) and 13 group B patients (56.5%) were in remission. In group A, 66.7% of the patients experienced side effects, versus 69.6% in group B. Infectious side effects were significantly more frequent in group B (69.6%) than in group A (40.7%) (P < 0.05). The incidence of Pneumocystis carinii pneumonia was higher in oral CYC‐treated patients (30.4%) than in pulse CYC‐treated patients (11.1%). Nine group A patients (33.3%) and 10 group B patients (43.5%) died. Actuarial curves showed that relapses were significantly more frequent in group A (59.2%) than in group B (13%) (P = 0.02). Conclusion. Our results indicate that pulse CYC is as effective as oral CYC in achieving initial remission of WG and is associated with fewer side effects and lower mortality. However, in the long term, treatment with pulse CYC does not maintain remission or prevent relapses as well as oral CYC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.1780401213

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 509

Metadata

Authors
Guillevin, L., Cordier, J., Lhote, F., Cohen, P., Jarrousse, B., Royer, I., Lesavre, P., Jacquot, C., Bindi, P., Bielefeld, P., Desson, J., Détrée, F., Dubois, A., Hachulla, E., Hoen, B., Jacomy, D., Seigneuric, C., Lauque, D., Stern, M., & Longy‐Boursier, M.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
1997-12
Volume
40
Issue
12
Pages
2187-2198
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2073208829
Cited by
509
References
1
FWCI
15.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis. https://app.cochat.ai/papers/10.1002/art.1780401213
The paper
Guillevin, L., Cordier, J., Lhote, F., Cohen, P., Jarrousse, B., Royer, I., Lesavre, P., Jacquot, C., Bindi, P., Bielefeld, P., Desson, J., Détrée, F., Dubois, A., Hachulla, E., Hoen, B., Jacomy, D., Seigneuric, C., Lauque, D., Stern, M., & Longy‐Boursier, M. (1997). A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780401213

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.